Directors combine broad industry experience

Opsona Therapeutics has an active board of directors with a wealth of experience in the global pharmaceutical industry.

Manus Rogan

Dr Manus Rogan
Chairman and Investor Director

  • Managing Partner for Fountain Healthcare Partners
  • Was previously responsible for licensing Elan's products and drug development technologies in Europe and Japan
  • Joined Elan's corporate VC group in the US, where he was involved in the sourcing, screening and management of investments in private and public biotechnology companies
  • Holds an MBA from Trinity College and a PhD in chemistry 


Professor Luke O’Neill, Founder Director, Opsona

Professor Luke O'Neill
Founder and Independent Director

  • One of the world's foremost authorities in the innate immune system
  • Global TLR signalling opinion leader and researcher
  • Chair of European Science Foundation Immunology Panel and Professor of Biochemistry & Immunology at Trinity College Dublin


Bernd Seizinger

Dr Bernd Seizinger
Independent Director

  • President and Chief Executive Officer of GPC Biotech (Munich, Germany and Princeton, NJ, USA) from 1998-2009
  • Previously Vice President of Oncology Drug Discovery and - in parallel - Vice President of Corporate and Academic Alliances at Bristol-Myers Squibb
  • Is a board member of three other biotechnology companies


Dr. Alan O'Connell

Dr Alan O'Connell
Investor Director

  • Partner for Seroba Life Sciences
  • Former executive in product and business development pharma/ biotech industry
  • Ex-Estée Lauder Investments (New York)
  • Holds MSc (University of London) and Ph.D in pharmacology (National University of Ireland, Galway)


Florent Gros

Mr Florent Gros
Investor Director

  • Managing Director of the Novartis Venture Fund in Basel, Switzerland
  • Has held various positions in IP and venture capital for Nestlé, Aventis-Pasteur and Novartis
  • Experience in management of IP, BD and M&A
  • Holds European and French patent lawyer degrees 


Martin Muenchback

Dr Martin Muenchbach
Investor Director

  • Partner at BB Biotech Ventures
  • Former Investment Manager at NMT New Medical Technologies, Marketing at Sanofi-Synthelabo SA
  • MBA and PhD in Proteinchemistry ETH Zurich, Switzerland


Peter Bensen Investor Director Opsona

Mr Peter Benson
Investor Director

  • Managing Partner and co-founder of Sunstone Capital in Copenhagen, Denmark
  • Previously Senior Vice President, Global Head of Hospital Care at Pharmacia
  • Acted as start-up CEO, business angel and board member of more than 20 life science companies
  • Holds a B.Sc. in Business Administration from University of Lund and an M.A. Economics from University of California



Dr. Jan Adams
Investor Director

  • Partner at EMBL Ventures
  • Former postdoctoral Fellow of the Ernst Schering Research Foundation at the University of Granada, Spain
  • Former Fellow of the Boehringer Ingelheim Research Foundation
  • M.S. in Biochemistry & Molecular Biology from Tübingen University, Germany
  • PhD in Genetics from the University of Cambridge, UK

Ms. Monique Schiersing
Investor Director

  • Investment Director at the Roche Venture Fund, Roche’s CHF 500M corporate venture fund
  • Previously, held positions at BankInvest Biomedical Venture in Copenhagen, Roche Partnering in various roles incl. Global Alliance Director being responsible for Roche Pharma’s early stage biologics collaborations, Bay City Capital and Tularik, Inc.
  • M.S. from the University of Zurich and MBA from University of San Francisco

Learn more

Read about Opsona's management team